Eli Lilly weight loss drug Zepbound effective in sleep apnea trials

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. Brendan McDermid | ReutersEli Lilly on Wednesday said its highly popular weight loss drug Zepbound showed the potential to treat patients with the most common sleep-related breathing disorder in two...

Read more...

Eli Lilly’s Zepbound, Mounjaro in short supply through June, FDA says 

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. Brendan McDermid | ReutersMost doses of Eli Lilly's highly popular weight loss drug Zepbound and diabetes counterpart Mounjaro will be in short supply through the second quarter of this year...

Read more...

LLY, TRV, UAL, AA and more

Check out the companies making the biggest moves in premarket trading: Eli Lilly , ResMed — Eli Lilly's stock moved 2% higher following the pharmaceutical giant's announcement that its weight loss drug Zepbound showed the potential to treat patients with obstructive sleep apnea. Shares of ResMed, which makes devices...

Read more...

Inside LemFi’s play to be fintech to the Global South diaspora

The African tech ecosystem, buffeted by huge potential but also lots of economic, political and social instabilities, is no stranger to major drama affecting even its most promising-looking startups. But recently, LemFi, the Nigeria-based fintech that provides money transfer services to African migrants, is shaping up as an example...

Read more...